nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—rheumatoid arthritis	0.35	1	CbGaD
Lumiracoxib—PTGS2—Triamcinolone—rheumatoid arthritis	0.0905	0.151	CbGbCtD
Lumiracoxib—PTGS2—Sulfasalazine—rheumatoid arthritis	0.0905	0.151	CbGbCtD
Lumiracoxib—PTGS2—Betamethasone—rheumatoid arthritis	0.0777	0.129	CbGbCtD
Lumiracoxib—PTGS1—Sulfasalazine—rheumatoid arthritis	0.0764	0.127	CbGbCtD
Lumiracoxib—CYP1A2—Leflunomide—rheumatoid arthritis	0.0553	0.0921	CbGbCtD
Lumiracoxib—CYP2C9—Leflunomide—rheumatoid arthritis	0.0498	0.083	CbGbCtD
Lumiracoxib—PTGS2—Dexamethasone—rheumatoid arthritis	0.0452	0.0753	CbGbCtD
Lumiracoxib—CYP2C19—Prednisone—rheumatoid arthritis	0.0296	0.0493	CbGbCtD
Lumiracoxib—CYP2C19—Cyclosporine—rheumatoid arthritis	0.028	0.0467	CbGbCtD
Lumiracoxib—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0233	0.0389	CbGbCtD
Lumiracoxib—CYP2C19—Dexamethasone—rheumatoid arthritis	0.0185	0.0308	CbGbCtD
Lumiracoxib—CYP2C9—Dexamethasone—rheumatoid arthritis	0.0154	0.0256	CbGbCtD
Lumiracoxib—Meclofenamic acid—ALOX5—rheumatoid arthritis	0.00165	0.208	CrCbGaD
Lumiracoxib—Tolmetin—CXCL8—rheumatoid arthritis	0.00139	0.175	CrCbGaD
Lumiracoxib—Tolmetin—MPO—rheumatoid arthritis	0.00108	0.136	CrCbGaD
Lumiracoxib—Diclofenac—ALOX5—rheumatoid arthritis	0.000923	0.116	CrCbGaD
Lumiracoxib—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.000795	0.159	CbGdCrCtD
Lumiracoxib—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.000782	0.156	CbGdCrCtD
Lumiracoxib—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.000782	0.156	CbGdCrCtD
Lumiracoxib—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.000765	0.153	CbGdCrCtD
Lumiracoxib—Diclofenac—CXCL8—rheumatoid arthritis	0.000764	0.0962	CrCbGaD
Lumiracoxib—Bromfenac—PTGS2—rheumatoid arthritis	0.000602	0.0758	CrCbGaD
Lumiracoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	0.00048	0.0958	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	0.000472	0.0942	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	0.000472	0.0942	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	0.000461	0.0921	CbGdCrCtD
Lumiracoxib—Tolmetin—PTGS2—rheumatoid arthritis	0.000405	0.051	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS2—rheumatoid arthritis	0.000399	0.0502	CrCbGaD
Lumiracoxib—Mefenamic acid—PTGS2—rheumatoid arthritis	0.00031	0.0391	CrCbGaD
Lumiracoxib—Diclofenac—PTGS2—rheumatoid arthritis	0.000223	0.0281	CrCbGaD
Lumiracoxib—Diclofenac—ALB—rheumatoid arthritis	0.000199	0.025	CrCbGaD
Lumiracoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	6.55e-05	0.00177	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—CCL2—rheumatoid arthritis	6.49e-05	0.00175	CbGpPWpGaD
Lumiracoxib—CYP1A2—Melatonin metabolism and effects—NFKB1—rheumatoid arthritis	6.32e-05	0.00171	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	6.23e-05	0.00168	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	6.21e-05	0.00168	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—LEP—rheumatoid arthritis	6.11e-05	0.00165	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	6.06e-05	0.00164	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	6.06e-05	0.00164	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—ALB—rheumatoid arthritis	6.05e-05	0.00163	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	6.04e-05	0.00163	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	6.01e-05	0.00162	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—POMC—rheumatoid arthritis	6e-05	0.00162	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TLR4—rheumatoid arthritis	5.99e-05	0.00162	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	5.98e-05	0.00161	CbGpPWpGaD
Lumiracoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	5.97e-05	0.00161	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	5.88e-05	0.00159	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	5.82e-05	0.00157	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	5.79e-05	0.00156	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—FADS2—rheumatoid arthritis	5.77e-05	0.00156	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—ICAM1—rheumatoid arthritis	5.74e-05	0.00155	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—NOS2—rheumatoid arthritis	5.69e-05	0.00154	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	5.64e-05	0.00152	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—rheumatoid arthritis	5.62e-05	0.00152	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CD4—rheumatoid arthritis	5.54e-05	0.0015	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IFNG—rheumatoid arthritis	5.52e-05	0.00149	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	5.51e-05	0.00149	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	5.31e-05	0.00143	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—rheumatoid arthritis	5.25e-05	0.00142	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CCL2—rheumatoid arthritis	5.14e-05	0.00139	CbGpPWpGaD
Lumiracoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	5.1e-05	0.00138	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—rheumatoid arthritis	5.03e-05	0.00136	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	4.99e-05	0.00135	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	4.94e-05	0.00133	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	4.93e-05	0.00133	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—POMC—rheumatoid arthritis	4.89e-05	0.00132	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	4.84e-05	0.00131	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	4.8e-05	0.0013	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PLD4—rheumatoid arthritis	4.72e-05	0.00128	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	4.71e-05	0.00127	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	4.7e-05	0.00127	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—rheumatoid arthritis	4.68e-05	0.00127	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—rheumatoid arthritis	4.67e-05	0.00126	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	4.6e-05	0.00124	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—FADS2—rheumatoid arthritis	4.58e-05	0.00124	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ACAN—rheumatoid arthritis	4.56e-05	0.00123	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	4.55e-05	0.00123	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	4.53e-05	0.00122	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—TNF—rheumatoid arthritis	4.5e-05	0.00122	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	4.4e-05	0.00119	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	4.4e-05	0.00119	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—rheumatoid arthritis	4.37e-05	0.00118	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IFNG—rheumatoid arthritis	4.37e-05	0.00118	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—SLC25A12—rheumatoid arthritis	4.29e-05	0.00116	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGES—rheumatoid arthritis	4.17e-05	0.00113	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GC—rheumatoid arthritis	4.17e-05	0.00113	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	4.14e-05	0.00112	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	4.09e-05	0.00111	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CXCL8—rheumatoid arthritis	4.06e-05	0.0011	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	4.02e-05	0.00108	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	4.02e-05	0.00108	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—rheumatoid arthritis	3.97e-05	0.00107	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SYVN1—rheumatoid arthritis	3.96e-05	0.00107	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—TGFB1—rheumatoid arthritis	3.95e-05	0.00107	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL1B—rheumatoid arthritis	3.9e-05	0.00105	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	3.88e-05	0.00105	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL2—rheumatoid arthritis	3.88e-05	0.00105	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PLB1—rheumatoid arthritis	3.88e-05	0.00105	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PLD4—rheumatoid arthritis	3.85e-05	0.00104	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	3.81e-05	0.00103	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	3.73e-05	0.00101	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ACAN—rheumatoid arthritis	3.72e-05	0.001	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MMP9—rheumatoid arthritis	3.67e-05	0.000992	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—rheumatoid arthritis	3.64e-05	0.000983	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL6—rheumatoid arthritis	3.63e-05	0.000981	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	3.59e-05	0.00097	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—TNF—rheumatoid arthritis	3.57e-05	0.000965	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ACAN—rheumatoid arthritis	3.53e-05	0.000952	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—SLC25A12—rheumatoid arthritis	3.5e-05	0.000944	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	3.43e-05	0.000927	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	3.43e-05	0.000927	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GC—rheumatoid arthritis	3.4e-05	0.000919	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGES—rheumatoid arthritis	3.4e-05	0.000919	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—MED1—rheumatoid arthritis	3.4e-05	0.000919	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	3.4e-05	0.000918	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—rheumatoid arthritis	3.4e-05	0.000918	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—FADS2—rheumatoid arthritis	3.33e-05	0.000899	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SLC25A12—rheumatoid arthritis	3.31e-05	0.000895	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	3.27e-05	0.000884	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	3.19e-05	0.000862	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ACP5—rheumatoid arthritis	3.16e-05	0.000854	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PLB1—rheumatoid arthritis	3.16e-05	0.000854	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—B3GNT2—rheumatoid arthritis	3.16e-05	0.000854	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PLD4—rheumatoid arthritis	3.06e-05	0.000826	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—FADS2—rheumatoid arthritis	3.03e-05	0.000819	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TGFB1—rheumatoid arthritis	3.03e-05	0.000818	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PLB1—rheumatoid arthritis	3e-05	0.00081	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ACAN—rheumatoid arthritis	2.95e-05	0.000797	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL6—rheumatoid arthritis	2.88e-05	0.000779	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—BGN—rheumatoid arthritis	2.85e-05	0.000769	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNF—rheumatoid arthritis	2.83e-05	0.000763	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—POMC—rheumatoid arthritis	2.82e-05	0.000762	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	2.8e-05	0.000755	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SLC25A12—rheumatoid arthritis	2.78e-05	0.00075	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—MED1—rheumatoid arthritis	2.77e-05	0.000749	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—RBPJ—rheumatoid arthritis	2.77e-05	0.000747	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.77e-05	0.000747	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GC—rheumatoid arthritis	2.7e-05	0.000729	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTGES—rheumatoid arthritis	2.7e-05	0.000729	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALOX5—rheumatoid arthritis	2.62e-05	0.000708	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—FADS2—rheumatoid arthritis	2.59e-05	0.0007	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—B3GNT2—rheumatoid arthritis	2.58e-05	0.000696	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ACP5—rheumatoid arthritis	2.58e-05	0.000696	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—POMC—rheumatoid arthritis	2.57e-05	0.000695	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.52e-05	0.000681	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PLB1—rheumatoid arthritis	2.51e-05	0.000678	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TP53—rheumatoid arthritis	2.49e-05	0.000673	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	2.47e-05	0.000668	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ACP5—rheumatoid arthritis	2.44e-05	0.00066	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—B3GNT2—rheumatoid arthritis	2.44e-05	0.00066	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	2.43e-05	0.000656	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—BGN—rheumatoid arthritis	2.32e-05	0.000627	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.3e-05	0.000622	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL6—rheumatoid arthritis	2.28e-05	0.000616	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	2.24e-05	0.000606	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PLD4—rheumatoid arthritis	2.22e-05	0.0006	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—MED1—rheumatoid arthritis	2.2e-05	0.000595	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TLE3—rheumatoid arthritis	2.2e-05	0.000594	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—BGN—rheumatoid arthritis	2.2e-05	0.000594	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—POMC—rheumatoid arthritis	2.2e-05	0.000594	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.15e-05	0.000582	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ACAN—rheumatoid arthritis	2.14e-05	0.000579	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALOX5—rheumatoid arthritis	2.14e-05	0.000577	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ENO1—rheumatoid arthritis	2.14e-05	0.000577	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.1e-05	0.000567	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	2.06e-05	0.000556	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ACP5—rheumatoid arthritis	2.05e-05	0.000553	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—B3GNT2—rheumatoid arthritis	2.05e-05	0.000553	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	2.02e-05	0.000547	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC25A12—rheumatoid arthritis	2.02e-05	0.000544	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SLC11A1—rheumatoid arthritis	2.01e-05	0.000542	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NFATC1—rheumatoid arthritis	1.99e-05	0.000538	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GC—rheumatoid arthritis	1.96e-05	0.00053	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGES—rheumatoid arthritis	1.96e-05	0.00053	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	1.96e-05	0.000528	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1.92e-05	0.000519	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.88e-05	0.000507	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NCF2—rheumatoid arthritis	1.85e-05	0.0005	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—BGN—rheumatoid arthritis	1.84e-05	0.000498	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	1.84e-05	0.000496	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.84e-05	0.000496	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PLB1—rheumatoid arthritis	1.82e-05	0.000492	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	1.79e-05	0.000483	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GC—rheumatoid arthritis	1.79e-05	0.000483	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ENO1—rheumatoid arthritis	1.74e-05	0.00047	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PLD4—rheumatoid arthritis	1.73e-05	0.000467	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.71e-05	0.000463	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SAA1—rheumatoid arthritis	1.7e-05	0.00046	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	1.7e-05	0.000458	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	1.7e-05	0.000458	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ACAN—rheumatoid arthritis	1.67e-05	0.000451	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NCF1—rheumatoid arthritis	1.67e-05	0.00045	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	1.66e-05	0.000449	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ENO1—rheumatoid arthritis	1.65e-05	0.000446	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD28—rheumatoid arthritis	1.6e-05	0.000433	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MED1—rheumatoid arthritis	1.6e-05	0.000432	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	1.57e-05	0.000424	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CAT—rheumatoid arthritis	1.54e-05	0.000415	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GC—rheumatoid arthritis	1.53e-05	0.000413	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	1.53e-05	0.000413	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—UBE2D1—rheumatoid arthritis	1.51e-05	0.000408	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.5e-05	0.000405	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.49e-05	0.000403	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—B3GNT2—rheumatoid arthritis	1.49e-05	0.000401	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ACP5—rheumatoid arthritis	1.49e-05	0.000401	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ADRBK1—rheumatoid arthritis	1.46e-05	0.000395	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MED1—rheumatoid arthritis	1.46e-05	0.000394	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	1.42e-05	0.000384	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ENO1—rheumatoid arthritis	1.38e-05	0.000373	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.36e-05	0.000367	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	1.36e-05	0.000366	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	1.36e-05	0.000366	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PRKCQ—rheumatoid arthritis	1.35e-05	0.000365	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—BGN—rheumatoid arthritis	1.34e-05	0.000361	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—STAT1—rheumatoid arthritis	1.33e-05	0.000358	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—MTHFR—rheumatoid arthritis	1.28e-05	0.000347	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CAT—rheumatoid arthritis	1.25e-05	0.000339	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MED1—rheumatoid arthritis	1.25e-05	0.000336	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALOX5—rheumatoid arthritis	1.23e-05	0.000333	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—BGN—rheumatoid arthritis	1.22e-05	0.00033	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	1.16e-05	0.000313	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	1.16e-05	0.000313	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	1.12e-05	0.000303	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.08e-05	0.000293	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—MTHFR—rheumatoid arthritis	1.05e-05	0.000283	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—BGN—rheumatoid arthritis	1.04e-05	0.000282	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—POMC—rheumatoid arthritis	1.03e-05	0.000277	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CCR5—rheumatoid arthritis	1.01e-05	0.000274	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	1e-05	0.000271	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CAT—rheumatoid arthritis	9.95e-06	0.000269	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MTHFR—rheumatoid arthritis	9.92e-06	0.000268	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HLA-A—rheumatoid arthritis	9.89e-06	0.000267	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	9.88e-06	0.000267	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	9.87e-06	0.000267	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	9.6e-06	0.000259	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALB—rheumatoid arthritis	9.36e-06	0.000253	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	9.15e-06	0.000247	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	9e-06	0.000243	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NOS3—rheumatoid arthritis	8.95e-06	0.000242	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6ST—rheumatoid arthritis	8.67e-06	0.000234	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	8.64e-06	0.000233	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS2—rheumatoid arthritis	8.6e-06	0.000232	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	8.44e-06	0.000228	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—POMC—rheumatoid arthritis	8.37e-06	0.000226	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD80—rheumatoid arthritis	8.35e-06	0.000225	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	8.3e-06	0.000224	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—rheumatoid arthritis	8.19e-06	0.000221	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.88e-06	0.000213	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	7.82e-06	0.000211	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6R—rheumatoid arthritis	7.74e-06	0.000209	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	7.69e-06	0.000208	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALB—rheumatoid arthritis	7.63e-06	0.000206	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NOS3—rheumatoid arthritis	7.3e-06	0.000197	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CAT—rheumatoid arthritis	7.23e-06	0.000195	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TYK2—rheumatoid arthritis	7.05e-06	0.00019	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS3—rheumatoid arthritis	6.92e-06	0.000187	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	6.73e-06	0.000182	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—rheumatoid arthritis	6.67e-06	0.00018	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—POMC—rheumatoid arthritis	6.64e-06	0.000179	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CAT—rheumatoid arthritis	6.59e-06	0.000178	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD4—rheumatoid arthritis	6.37e-06	0.000172	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALB—rheumatoid arthritis	6.05e-06	0.000164	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	6.03e-06	0.000163	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NOS3—rheumatoid arthritis	5.79e-06	0.000156	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CAT—rheumatoid arthritis	5.63e-06	0.000152	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	5.5e-06	0.000149	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—POMC—rheumatoid arthritis	4.82e-06	0.00013	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	4.7e-06	0.000127	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFB1—rheumatoid arthritis	4.57e-06	0.000124	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—POMC—rheumatoid arthritis	4.4e-06	0.000119	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALB—rheumatoid arthritis	4.4e-06	0.000119	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	4.21e-06	0.000114	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALB—rheumatoid arthritis	4.01e-06	0.000108	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	3.85e-06	0.000104	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	3.84e-06	0.000104	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—POMC—rheumatoid arthritis	3.76e-06	0.000102	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	3.51e-06	9.47e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—rheumatoid arthritis	3.45e-06	9.31e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALB—rheumatoid arthritis	3.43e-06	9.25e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	3.28e-06	8.85e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	3e-06	8.1e-05	CbGpPWpGaD
